Leading research progress and prospect of antibody-drug conjugate in pancreatic cancer in 2022

Leading research progress and prospect of antibody-drug conjugate in pancreatic cancer in 2022

Pancreatic cancer is a type of malignant tumor with high incidence and low survival rate. It is urgent to develop novel and efficient therapeutic means for patients lacking surgical indications and patients with poor effects of radiotherapy and chemotherapy. In recent years, antibody-drug conjugate...

Full description

Bibliographic Details
Main Author:	ZENG Cheng, ZHANG Jian
Format:	Article
Language:	English
Published:	Editorial Office of China Oncology 2023-03-01
Series:	Zhongguo aizheng zazhi
Subjects:	\|antibody-drug conjugate\|pancreatic cancer\|clinical research
Online Access:	http://www.china-oncology.com/fileup/1007-3639/PDF/1681714792661-1562991861.pdf

Similar Items

Antibody drug conjugates: hitting the mark in pancreatic cancer?
by: Nicole L. Wittwer, et al.
Published: (2023-10-01)

Antibody-drug conjugates for the treatment of lymphoma: clinical advances and latest progress
by: Yurou Chu, et al.
Published: (2021-06-01)

Therapeutic effect of a MUC1-specific monoclonal antibody-drug conjugates against pancreatic cancer model
by: Guang Wu, et al.
Published: (2022-12-01)

Toward Homogenous Antibody Drug Conjugates Using Enzyme-Based Conjugation Approaches
by: Ahmad Fawzi Hussain, et al.
Published: (2021-04-01)

Antibody–Drug Conjugates: Ushering in a New Era of Cancer Therapy
by: Joshua Hurwitz, et al.
Published: (2023-07-01)

Recent advances of antibody drug conjugates for clinical applications
by: Pengxuan Zhao, et al.
Published: (2020-09-01)

Trends in the Development of Antibody-Drug Conjugates for Cancer Therapy
by: Chi Hun Song, et al.
Published: (2023-11-01)

Antibody Drug Conjugates for Cancer Therapy
by: S M Gheibi hayat, et al.
Published: (2017-07-01)

Development of Photoremovable Linkers as a Novel Strategy to Improve the Pharmacokinetics of Drug Conjugates and Their Potential Application in Antibody–Drug Conjugates for Cancer Therapy
by: Audrey Nathania Johan, et al.
Published: (2022-05-01)

Exploration of the antibody–drug conjugate clinical landscape
by: Heather Maecker, et al.
Published: (2023-12-01)

Monoclonal Antibodies and Antibody Drug Conjugates in Multiple Myeloma
by: Jakub Radocha, et al.
Published: (2021-03-01)

Marine Antibody–Drug Conjugates: Design Strategies and Research Progress
by: Yu-Jie Wang, et al.
Published: (2017-01-01)

Learn from antibody–drug conjugates: consideration in the future construction of peptide-drug conjugates for cancer therapy
by: Mo Wu, et al.
Published: (2022-11-01)

Knowledge atlas of antibody-drug conjugates on CiteSpace and clinical trial visualization analysis
by: Peizhuo Yao, et al.
Published: (2023-01-01)

Physical characteristics comparison between maytansinoid-based and auristatin-based antibody-drug conjugates
by: Tomohiro Fujii, et al.
Published: (2021-12-01)

Research Progress of Antibody-drug Conjugates in Small-cell Lung Cancer
by: HAN Jing, et al.
Published: (2023-11-01)

Antibody-Based Approaches to Target Pancreatic Tumours
by: Marie Sorbara, et al.
Published: (2022-07-01)

Bispecific Antibodies and Antibody–Drug Conjugates for Cancer Therapy: Technological Considerations
by: Hyunbo Shim
Published: (2020-02-01)

How Far Have We Developed Antibody–Drug Conjugate for the Treatment of Cancer?
by: Yu Jun Lim, et al.
Published: (2023-05-01)

Antibody Drug Conjugates as Cancer Therapeutics
by: Pamela A. Trail
Published: (2013-02-01)

A Novel c-MET-Targeting Antibody-Drug Conjugate for Pancreatic Cancer
by: Yangbing Jin, et al.
Published: (2021-03-01)

Quantification of an Antibody-Conjugated Drug in Fat Plasma by an Affinity Capture LC-MS/MS Method for a Novel Prenyl Transferase-Mediated Site-Specific Antibody–Drug Conjugate
by: Byeong ill Lee, et al.
Published: (2020-03-01)

An Overview of Antibody Conjugated Polymeric Nanoparticles for Breast Cancer Therapy
by: Alberto Juan, et al.
Published: (2020-08-01)

Current and emerging monoclonal antibodies, antibody-drug conjugates, and bispecific antibodies in treatment of lymphoma
by: Suheil Albert Atallah-Yunes, et al.
Published: (2022-01-01)

Antibody-drug conjugates for cancer therapy
by: Anna Grzywa
Published: (2021-11-01)

Current Progress and Future Developments of Antibody Drug Conjugates  in Lung Cancer
by: Yixiang ZHU, et al.
Published: (2022-07-01)

Mechanisms of Resistance to Antibody–Drug Conjugates
by: Rachel Occhiogrosso Abelman, et al.
Published: (2023-02-01)

A glypican-1-targeted antibody-drug conjugate exhibits potent tumor growth inhibition in glypican-1-positive pancreatic cancer and esophageal squamous cell carcinoma
by: Eri Munekage, et al.
Published: (2021-09-01)

Antibody–Drug Conjugates for the Treatment of Breast Cancer
by: Chiara Corti, et al.
Published: (2021-06-01)

Rapid Evaluation of Antibody Fragment Endocytosis for Antibody Fragment–Drug Conjugates
by: Eunhee G. Kim, et al.
Published: (2020-06-01)

Design and Validation of Linkers for Site-Specific Preparation of Antibody–Drug Conjugates Carrying Multiple Drug Copies Per Cysteine Conjugation Site
by: Amit Kumar, et al.
Published: (2020-09-01)

Antibody–Drug Conjugates for Cancer Therapy
by: Umbreen Hafeez, et al.
Published: (2020-10-01)

Advances in targeted therapy for pancreatic cancer
by: Lin Xing, et al.
Published: (2023-12-01)

Development of Apoptotic-Cell-Inspired Antibody–Drug Conjugate for Effective Immune Modulation
by: Gyeongwoo Lee, et al.
Published: (2023-11-01)

Antibody conjugates and malignant disease /
by: 399966 Magerstadt, Michael
Published: (1990)

Antibody‐Drug Conjugates to Treat Bacterial Biofilms via Targeting and Extracellular Drug Release
by: Anne Tvilum, et al.
Published: (2023-08-01)

A review of the clinical efficacy of FDA-approved antibody‒drug conjugates in human cancers
by: Kaifeng Liu, et al.
Published: (2024-03-01)

Antibody–Drug Conjugates in Breast Cancer: Current Status and Future Directions
by: Cynthia Mark, et al.
Published: (2023-09-01)

Characterizing and understanding the formation of cysteine conjugates and other by-products in a random, lysine-linked antibody drug conjugate
by: Difei Qiu, et al.
Published: (2021-01-01)

Research Progress of Antibody–Drug Conjugate Therapy for Advanced Gastric Cancer
by: Na Wang, et al.
Published: (2022-05-01)